News
Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta
Company Statement & FAQs on Plasmid Insertion Found in First Gene-Edited Bull
Precision Breeding’s New Horizons
Recombinetics Awarded National Institutes of Health Funding to Develop Genetically Engineered Swine Model of Glioblastoma, the Deadliest Type of Brain Tumor
The Alliance to End Surgical Castration of Swine Announces Precision Breeding Successes
Acceligen and Kheiron-Biotech Announce Joint Projects Focused on Precision Breeding
From TALENs to the Table
Recombinetics Names Dr. Tad Sonstegard the First Chief Executive Officer of Its Wholly-Owned Subsidiary, Acceligen
